Natco seeks CDSCO approval for phase-III trial of Molnupiravir for Covid-19 treatment
Natco seeks CDSCO approval for phase-III trial of Molnupiravir for Covid-19 treatment Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of phase-III clinical trial of Molnupiravir capsules for the treatment of Covid-19 positive patients. https://ift.tt/eA8V8J
India hits new record with COVID-19 infections, US vows aid
India hits new record with COVID-19 infections, US vows aid
https://ift.tt/3tTIFvw April 26, 2021 at 01:54PM https://ift.tt/1R552o9
submitted by /u/easywaycentre [link] [comments] |
Biocon Biologics, Viatris receive approval for cancer drug
Biocon Biologics, Viatris receive approval for cancer drug Abevmy is approved for treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen. https://ift.tt/eA8V8J
Subscribe to:
Posts (Atom)
Subscribe UsPopular Posts
|